A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV.
Clinical trial NCT06617091 · RECRUITING
Trial details
- NCT number
- NCT06617091
- Sponsor
- International AIDS Vaccine Initiative
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-28
- Primary completion
- 2027-03-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.